首页 | 本学科首页   官方微博 | 高级检索  
检索        


Eye-Preserving Therapies for Advanced Retinoblastoma: A Multicenter Cohort of 1678 Patients in China
Institution:1. Department of Ophthalmology, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China;2. Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China;3. Department of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China;4. Department of Ophthalmology, Beijing Children’s Hospital, Capital Medical University, Beijing, China;5. Department of Interventional Radiology and Vascular Anomalies, Guangzhou Women and Children’s Medical Center, Guangzhou, China;6. Department of Ophthalmology, Xiangya Hospital, Central South University, Changsha, China;7. Department of Ophthalmology, Qilu Children’s Hospital of Shandong University, Jinan, China;8. Department of Ophthalmology, Army Medical Center of PLA, Chongqing, China;9. Department of Ophthalmology, Kunming Children’s Hospital, Kunming, China;10. Department of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan, China;11. Department of Ophthalmology, Hebei Children’s Hospital, Shijiazhuang, China;12. Department of Ophthalmology, Tangdu Hospital, The Fourth Military Medical University, Xi''an, China;13. Department of Ophthalmology, Harbin Children’s Hospital, Harbin, China;14. Department of Ophthalmology, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), University of Science and Technology of China, Hefei, China;15. Department of Ophthalmology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China;16. Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China;17. Department of Ophthalmology, Children’s Hospital of Nanjing Medical University, Nanjing, China;18. Department of Ophthalmology, Second Provincial People’s Hospital of Gansu, Lanzhou, China;19. Department of Ophthalmology, The Second Hospital of Dalian Medical University, Dalian, China;20. Department of Ocular Trauma and Orbital Diseases, Affiliated Eye Hospital of Nanchang University, Nanchang, China;21. Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, China;22. Department of Ophthalmology, The Affiliated Hospital of Inner Mongolia Medical University, Huhhot, China;23. Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, China;24. Department of Ophthalmology, Affiliated Shenzhen Eye Hospital of Ji-nan University, Shenzhen, China;25. Department of Ophthalmology, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China;26. Department of Ophthalmology, Tibet Autonomous Region Eye Center, Tibetan Medicine Hospital, Lhasa, China;27. Department of Ophthalmology, The General Hospital of Xinjiang Military Command of PLA, Urumchi, China;28. Department of Ophthalmology, Kashgar Prefecture Second People’s Hospital, Kashgar, China;29. Department of Ophthalmology, Hainan Eye Hospital and Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Haikou, China;30. Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China;31. Department of Ophthalmology, Tianjin Medical University Eye Hospital, Tianjin, China;32. Department of Ophthalmology, NingXia Eye Hospital, People’s Hospital of Ningxia Hui Autonomous Region, Yinchuan, China;33. Department of Ophthalmology, Qinghai University Affiliated Hospital, Xining, China;34. National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China;35. Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Department of Bioinformatics and Biostatistics, Shanghai Jiao Tong University, Shanghai, China;36. Department of Ophthalmology, Peking University People’s Hospital, Beijing, China;37. Department of Ophthalmology, Henan Children’s Hospital, Zhengzhou, China;38. Department of Ophthalmology, Quanzhou Women’s and Children’s Hospital, Quanzhou, China;39. Department of Ophthalmology, The General Hospital of Chinese People’s Armed Police Forces, Beijing, China;40. Department of Ophthalmology, Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China;41. Chuandi Zhou’s current affiliation is Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China;1. School of Medicine, Vanderbilt University, Nashville, Tennessee;2. Department of Biostatistics, Vanderbilt University, Nashville, Tennessee;3. Vanderbilt Eye Institute, Vanderbilt University, Nashville, Tennessee;1. Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland;2. Emmes Corporation, Rockville, Maryland;3. Age-Related Eye Disease Study 2 Research Group;1. Department of Ophthalmology, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China;2. Department of Pathology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China;1. Gavin Herbert Eye Institute, University of California, Irvine School of Medicine, Irvine, California;2. Illinois Eye and Ear Infirmary, University of Illinois College of Medicine at Chicago, Chicago, Illinois;3. Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts;4. Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, Tennessee;5. Ophthalmic Surgeons and Consultants of Ohio, Columbus, Ohio;6. Ophthalmic Plastic Surgery, Lions Eye Institute, Department of Ophthalmology, Albany Medical Center, Albany (Slingerlands), New York;7. Department of Ophthalmology, McGovern Medical School at University of Texas Health Science Center, Houston, Texas;8. Cullen Eye Institute, Baylor College of Medicine, Houston, Texas
Abstract:
Keywords:Cohort study  Enucleation  Eye-preserving therapies  Retinoblastoma  CI"}  {"#name":"keyword"  "$":{"id":"kwrd0035"}  "$$":[{"#name":"text"  "_":"confidence interval  HR"}  {"#name":"keyword"  "$":{"id":"kwrd0045"}  "$$":[{"#name":"text"  "_":"hazard ratio  IAC"}  {"#name":"keyword"  "$":{"id":"kwrd0055"}  "$$":[{"#name":"text"  "_":"intra-arterial chemotherapy  IVC"}  {"#name":"keyword"  "$":{"id":"kwrd0065"}  "$$":[{"#name":"text"  "_":"intravenous chemotherapy
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号